In turn, gain of p53 function activates a gene program that sensitizes lung myofibroblasts to apoptosis and promotes the clearance of apoptotic myofibroblasts by macrophages, suggesting that MDM4 may represent a molecular target in ageing-associated lung fibrosis. The gene discussed is TP53; the disease is pulmonary fibrosis.